| 2.395 0.085 (3.68%) | 10-04 10:23 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.54 | 1-year : | 4.13 |
| Resists | First : | 3.03 | Second : | 3.53 |
| Pivot price | 2.49 |
|||
| Supports | First : | 2.21 | Second : | 1.83 |
| MAs | MA(5) : | 2.42 |
MA(20) : | 2.59 |
| MA(100) : | 3.1 |
MA(250) : | 10.2 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 18.2 |
D(3) : | 21.2 |
| RSI | RSI(14): 38.1 |
|||
| 52-week | High : | 50.62 | Low : | 2.21 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ ATXI ] has closed above bottom band by 25.8%. Bollinger Bands are 20.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.46 - 2.47 | 2.47 - 2.49 |
| Low: | 2.32 - 2.33 | 2.33 - 2.35 |
| Close: | 2.4 - 2.42 | 2.42 - 2.44 |
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.
Fri, 27 Sep 2024
Avenue Therapeutics grants stock units to top executives - Investing.com
Fri, 27 Sep 2024
Week Ahead (Apr.12- Apr.16): PDUFA Dates, Data Readouts (RCUS, ATXI, MRTX, KDNY…) - RTTNews
Fri, 09 Aug 2024
Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - Yahoo Finance
Thu, 25 Jul 2024
Avenue Therapeutics hits 52-week low, trading at $3.18 - Investing.com
Thu, 20 Jun 2024
Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - Yahoo Finance
Mon, 29 Apr 2024
Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross Proceeds - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 1 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 13.1 (%) |
| Held by Institutions | 8.3 (%) |
| Shares Short | 15 (K) |
| Shares Short P.Month | 47 (K) |
| EPS | 37.47 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -201.4 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -9 (M) |
| Levered Free Cash Flow | -13 (M) |
| PE Ratio | 0.06 |
| PEG Ratio | 0 |
| Price to Book value | 0.57 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.39 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|